Pahl E, Miller S A, Griffith B P, Fricker F J
Department of Pediatrics, Children's Hospital, Pittsburgh, Pa, USA.
J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1109-15.
Although resting hemodynamics after pediatric heart transplantation are generally within normal limits, we hypothesized that occult restrictive hemodynamics suggesting diastolic dysfunction may be unmasked by acute volume loading (fluid challenge) during cardiac catheterization. We wished to determine the incidence of diastolic dysfunction and to assess whether it progressed over time.
From 1988 through 1993, a total of 100 fluid challenges were performed at the time of surveillance endomyocardial biopsy in 31 survivors of orthotopic heart transplantation. Cyclosporine-based immunosuppression was used in 16 patients, and FK506 was used in 15 patients. Right heart hemodynamics and cardiac output (thermodilution) were obtained at baseline and after a fluid challenge with 10 ml/kg of normal saline solution. The data were analyzed to determine whether type of immunosuppression or time elapsed since transplantation predicted the response to fluid challenge.
Baseline hemodynamics were normal; however, a marked increase in atrial filling pressures occurred after fluid challenge (p < 0.001). Findings were similar in cyclosporine- and FK506-treated patients. Hemodynamic response to fluid challenge was not related to duration of time since transplantation, including studies on patients surviving more than 4 years.
Diastolic dysfunction after heart transplantation is common; however, the abnormalities do not progress in severity, suggesting stable long-term graft function.
尽管小儿心脏移植后的静息血流动力学通常在正常范围内,但我们推测,心脏导管插入术中急性容量负荷(液体激发试验)可能会揭示提示舒张功能障碍的隐匿性限制性血流动力学。我们希望确定舒张功能障碍的发生率,并评估其是否随时间进展。
1988年至1993年期间,对31例原位心脏移植幸存者在监测性心内膜心肌活检时共进行了100次液体激发试验。16例患者使用基于环孢素的免疫抑制治疗,15例患者使用FK506。在基线时以及用10ml/kg生理盐水进行液体激发试验后,获取右心血流动力学和心输出量(热稀释法)数据。对数据进行分析,以确定免疫抑制类型或移植后经过的时间是否可预测对液体激发试验的反应。
基线血流动力学正常;然而,液体激发试验后心房充盈压显著升高(p<0.001)。环孢素和FK506治疗的患者结果相似。对液体激发试验的血流动力学反应与移植后的时间长短无关,包括对存活超过4年患者的研究。
心脏移植后舒张功能障碍很常见;然而,异常情况的严重程度并未进展,提示长期移植功能稳定。